Discover key insights from Vivos Therapeutics’ Q3 2025 earnings: strategic growth, 76% revenue surge, and future outlook in sleep disorder treatment.

Europe's industry and energy sector account for 40% of Europe's total water consumption and nearly a quarter of its final ...

Unfortunately, many eligible systems may forego participation because they may not realize they qualify, ignored the class ...

The House voted this week to reauthorize the State and Local Cybersecurity Grant Program for seven years, while also ...

New research shows that it's possible to end the practice of using people as human bait to catch and test the black flies ...

Gemini with Google Home is supposed to be like your own personal AI assistant. Our team put it to the test, but it seems like ...

As the global population races towards 9.7 billion by 2050, the world’s protein supply – an essential nutrient that builds ...

Help Jack Curtis fulfill a dream that seemed beyond impossible. Curtis has Stage 2 Hodgkin’s lymphoma. He is also a college quarterback. Typically, the first circumstance would at least temporarily ...

The UK has experienced a long string of disruptive cyber incidents, but the announcement of the cyber resilience bill cites ...

Leading Dubai-based physician believes the future of medicine lies in prevention and treating the human being as a whole ...

Silver is back in the market spotlight, with the metal topping $50 an ounce — a level last reached in 1980. Prices are up 70 ...

Q4 2025 Earnings Call November 13, 2025 11:00 AM ESTCompany ParticipantsDan Batrack - CEO & ChairmanSteven Burdick - CFO ...